Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Davidson, G.
International Journal of Pharmaceutical Compounding 6(5): 332-336
2002
ISSN/ISBN: 1092-4221 PMID: 23979410 Document Number: 540571
Document emailed within 1 workday
Related Documents
Elliott, D.A.; Nelson, R.W.; Feldman, E.C.; Neal, L.A. 1997: Glycosylated hemoglobin concentrations in the blood of healthy dogs and dogs with naturally developing diabetes mellitus, pancreatic beta-cell neoplasia, hyperadrenocorticism, and anemia Journal of the American Veterinary Medical Association 211(6): 723-727White, S.D. 1986: Facial dermatosis in four dogs with hyperadrenocorticism Journal of the American Veterinary Medical Association 188(12): 1441-1444
Hubbell, J.A. 1994: Compounding in veterinary anesthesiology Journal of the American Veterinary Medical Association 205(2): 202-204
Hurley, K.J.; Vaden, S.L. 1998: Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism Journal of the American Veterinary Medical Association 212(3): 369-373
Davidson, G.S. 2008: Veterinary compounding for myasthenia gravis International Journal of Pharmaceutical Compounding 12(5): 398-401
Jordan, D.G. 1997: Veterinary Compounding-A Bird's-eye View International Journal of Pharmaceutical Compounding 1(4): 222-227
Davidson, G. 2002: Navigating new territories in compounding for veterinary medicine International Journal of Pharmaceutical Compounding 6(5): 324-327
Kemp, D.T. 1994: Dilemmas in compounding for the veterinary teaching hospital Journal of the American Veterinary Medical Association 205(2): 263-267
Petrick, S.W. 1996: The incidence of eye disease in dogs in a veterinary academic hospital: 1772 cases Journal of the South African Veterinary Association 67(3): 108-110
Goodrum, J. 2005: Survey of state veterinary compounding laws and regulations International Journal of Pharmaceutical Compounding 9(3): 209-211
Gochenauer, A.E.; Holmes, E.R.; Barber, K.E.; Forsythe, L.R. 2019: The Current Landscape of Veterinary Compounding in the Pharmacy Setting International Journal of Pharmaceutical Compounding 23(5): 422-427
Allen, L.V.; Okeke, C.C. 2007: Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2 International Journal of Pharmaceutical Compounding 11(4): 313-323
Vermeulen, P.; Endenburg, N.; Lumeij, J.T. 2008: Numbers of dogs, cats, birds, and exotic animals in veterinary practices in the Netherlands 1994-2005 and possible consequences for the veterinary curriculum Tijdschrift Voor Diergeneeskunde 133(18): 760-763
Góth, M.; Szabolcs, I.; Kovács, Z.; Szilágyi, G. 1995: Anterior pituitary responsiveness in central Cushing disease and in Cushing syndrome caused by adrenal cortex tumors, as well as in simple obesity Orvosi Hetilap 136(2): 63-66
Richkind, M. 1981: Cushing syndrome in dogs: treatment with bromocriptine and cyproheptadine Veterinary Medicine-Small Animal Clinician 76(9): 1301-1304
Allen, L.V.; Okeke, C. 2007: Basics of compounding for the implementation of United States pharmaceopeia chapter 797 pharmaceutical compounding-sterile preparations, part 1 International Journal of Pharmaceutical Compounding 11(3): 230-236
Quertermous, J.; Desai, S.; Harper, J.; Lebwohl, M.; Torres, A.; Kircik, L.H. 2018: The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists Journal of Drugs in Dermatology: Jdd 17(7): S17-S22
Kowalczyk, D.F. 1976: Lead poisoning in dogs at the University of Pennsylvania Veterinary Hospital Journal of the American Veterinary Medical Association 168(5): 428-432
Van der Vlugt-Meijer, R.H. 2004: Severe adverse effects of certain veterinary drugs in collies and collie-like dogs Tijdschrift Voor Diergeneeskunde 129(17): 556-557
Allen, L.V. 1999: The basics of compounding: compounding gels International Journal of Pharmaceutical Compounding 3(5): 385-389